Late-outgrowth endothelial cells (OECs) exist in blood and other organs. We aimed to explore whether and how OECs participate in re-endothelialization and prevent vascular neointima formation after injury.
Introduction
Hyperplasia of the intima, i.e. neointima formation characterized by invasion of vascular smooth muscle cells (VSMCs), often happens and is the leading source of restenosis following revascularization procedures such as percutaneous balloon angioplasty, stent implantation, or atherectomy. 1 Among many contributory factors, endothelial denudation is usually the initial one. 2 Therefore, it is widely hypothesized that rapid re-endothelialization reduces neointima formation.
Re-endothelialization at spontaneous or iatrogenic disruption sites has classically been thought to be the result of the migration and proliferation of adjacent endothelial cells (ECs) within the vessel wall. However, local seeding with autologous 3, 4 or allogenic 5 ECs does not have a beneficial effect on the injured arteries. Endothelial progenitor cells (EPCs) exist in peripheral blood, bone marrow (BM) and other organs, 6, 7 and consist of early-outgrowth EPCs (eEPCs) and late-outgrowth ECs (OECs). 8, 9 Many investigations on mobilization or transfusion of eEPCs to reduce neointima formation have been performed, but the data are inconsistent. 10 -18 Besides accelerating re-endothelialization by a paracrine pathway, 19 eEPCs have the potential to differentiate into VSMCs, which contributes to hyperplasia of the intima. 20, 21 OECs better resemble ECs than eEPCs in morphology, cluster of differentiation (CD) molecules, and functional protein expressions, growth characteristics, and vascular network formation in vitro, and can incorporate into the newly formed blood vessels and differentiate into ECs. 8,9,19,22 -25 Nevertheless, few studies on the effects of OECs on neointima formation had been reported for a long time. Recently, a study showed that local seeding of allogenic OECs failed to prevent hyperplasia of the intima after rat carotid injury. 5 Two other reports showed that the transfused human OECs reduced, by a paracrine pathway, neointima formation in femoral arteries of athymic nude mice. 26, 27 Taken together, these three investigations suggest that transplant rejection might counteract the possibly beneficial effect of OECs, and transfusion of heterogenous OECs seems futureless for clinical use. Up to now, whether and how endogenous OECs participate in re-endothelialization and limit intimal hyperplasia remains unclear. We hypothesized that OECs participate directly in re-endothelialization, but their inhibitory effect on neointima formation is usually negligible owing to their limited numbers; transfusion of sufficient autologous OECs may reduce vascular neointima formation. This article reports our demonstration of the hypothesis.
Methods

Study approval and animals
The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication no. 85-23, revised 1996), and was approved by the Animal Administrative Committee of Xi'an Jiaotong University. Male Japanese white rabbits weighing 2.0-2.2 kg were supplied by the Laboratory Animal Center of Xi'an Jiaotong University.
Amplification of OECs
From rabbits anaesthetized with pentobarbital sodium, blood was drawn by cardiac puncture and BM drawn by femoral puncture. 28 The BM was treated with ammonium chloride solution (Stemcell Technologies), and the blood underwent density gradient centrifugation using Histopaque-1083 (Sigma) and treatment with ammonium chloride solution, to harvest mononuclear cells (MNCs; see Supplementary material online). The MNCs were plated on human fibronectin (for blood OECs, 1 mg/mL; Sigma) or rat collagen type I (for BM OECs, 50 mg/mL; Sigma) coated 5 100 mm culture dishes and eight-well chamber slides to culture for 28 days in endothelial basal medium-2 (EBM-2; Clonetics) containing supplements (SingleQuot Kit; Clonetics). The medium was changed every other day. Cells on dishes were subcultured on days 10, 15, 20 and 24.
Characterization and quantification of OECs 2.3.1 Morphology
Cells harvested were observed after staining with haemetoxylin and eosin (H&E).
Low-density lipoprotein uptake and Ulex europaeus agglutinin binding
Chamber slide-cultured cells were incubated with 1,1
′ -tetramethylindocarbocyanine-labelled acetylated low-density lipoprotein (Dil-acLDL; Molecular Probes) at 378C, fixed using paraformaldehyde, incubated with fluorescein isothiocyanate (FITC)-conjugated lectin from Ulex europaeus (FITC -lectin; Sigma) and Hoechst 33258 (Sigma) before being observed using a Nikon fluorescence microscope. Refer to Supplementary materials online for related details. 
CD144, CD14, and CD45
Nitric oxide production
Bone marrow-derived cells (2 × 10 6 ; 0, 7 and 28 days culture) were incubated in fetal bovine serum (FBS)-free EBM-2 for 24 h, then in 1 mL of EBM-2 containing FBS (10%), L-arginine (1.15 mM), bradykinin (0.1 mM), and 3-amino,4-aminomethyl-2 ′ ,7 ′ -difluorescein diacetate (5 mM; Beyotime, Haimen, China) for 12 h. The supernatants were assessed for fluorescence intensities using a fluorescence spectrophotometer calibrated for excitation at 495 nm and emission at 515 nm.
Caveolin-1
BM-derived cells (28 days culture) were plated on a chamber slide (1 × 10 4 /well) and allowed to attach overnight. They were fixed, and incubated in turn with mouse anti-caveolin-1 antibody (Abcam), FITC-conjugated goat anti-mouse IgG (Sigma) and Hoechst 33258 (Sigma) before observation using the fluorescence microscope.
Migration of OECs
The modified Boyden chamber assay 29 was used. Briefly, a transwell insert (Costar Transwell membrane, 6.5 mm diameter, 12.0 mm pore size) was placed in a 24-well dish. BM-derived OECs were plated in the upper wells (5 × 10 4 cells/well) to culture for 6, 12 or 24 h in EBM-2 containing vascular endothelial growth factor (VEGF, 50 mg/mL; Clonetics) and stromal cell-derived factor-1a (SDF-1a, 100 ng/mL; Sigma). Cells that migrated to the underside of the membrane were Hoechst stained after fixation for counting.
Tube formation in vitro
The OECs were plated on a Matrigel Matrix (BD Biosciences)-treated 48-well dish (5 × 10 4 /well) and cultured for 24 h with EBM-2 and supplements prior to observtion. 30 
Rabbit ear central artery injury
The artery was balloon injured directly, for in vitro ear perfusion, and was wire injured through a bifurcation, for in vivo study, as described in the Supplementary material online.
Treatment with autologous OECs
Thirty-five rabbits with amplified OECs were used 4 h after wire injury of their left ear central arteries. Ten of them were given 1 × 10 7 /kg, and ten were given 2 × 10 6 /kg of autologous OECs in phosphate-buffered saline (PBS), via the right ear lateral vein. Ten were given PBS (1 mL/kg). The remaining five rabbits were given Dil-acLDL-incorporated OECs (1 × 10 7 /kg). In the rabbits receiving the Dil-acLDL-incorporated OECs, the ear vasculature was observed in situ and real time using an inverted fluorescence microscope. Half the rabbits without Dil-acLDL-incorporated OECs were killed on day 14. The remaining rabbits were killed on day 28. Ten-micrometre-thick frozen sections of ear central arteries were stained with H&E. Indices of neointima formation were analysed with the image analysis system (Q550CW, Leica) as described in the Supplementary material online.
Analysis of inflammatory and angiogenic parameters
In a separate experiment, rabbit blood samples, on days 2 and 7, and ear central artery, on day 7 after transfusion of autologous OECs (1 × 10 7 / kg), were collected to measure levels of C-reactive protein, interleukin-8, SDF-1 and VEGF in serum, expression of allograft inflammatory factor-1 (AIF-1) in leucocytes, and expressions of tumour necrosis factor-a (TNF-a), AIF-1, endothelial nitric oxide synthase (eNOS), and SDF-1 in the injured arterial wall by ELISA or western blot. Refer to Supplementary material online for related details.
In vitro study of the adherence of OECs to the injured artery
Rabbit isolated ear perfusion 31 
5-Bromo-2
′ -deoxyuridine labelling of OECs and identification of 5-bromo-2 ′ -deoxyuridine-positive cells
The OECs were incubated in EBM-2 containing 5-bromo-2 ′ -deoxyuridine (BrdU, 5 mg/mL; Sigma) and 10% FBS for 48 h before transfusion to the rabbit. The BrdU-positive cells were identified by immunohistochemistry. Refer to Supplementary material online for related details. (5, 10, or 15%) . Then the cells were incubated for 4 h in PBS containing 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT, 0.5 mg/mL; Sigma) at 378C followed by elimination of supernatant and two washes. To each well was added 200 mL dimethyl sulphoxide, followed by a shaking for 10 min, and detection of the optical density three times using a microplate spectrophotometer (Bio-Rad) set to a wavelength of 490 nm.
Effects of OECs on VSMC migration
The modified Boyden chamber assay was used. Briefly, VSMCs (5 × 10 4 ; three or four passages) were plated in the upper well to culture for 4 h in DMEM containing FBS (5%) and human platelet-derived growth factor-BB (50 ng/mL; Sigma). For OEC groups, OECs (2.5 × 10 3 and 5 × 10 3 ) were plated in the lower well 12 h before VSMC plating. For the OECconditioned medium and EBM-2 groups, OEC-conditioned medium (5 and 10%) or EBM-2 (10%) was added into the culture medium. The VSMCs on the underside of the membrane (8.0 mm pore size) were Hoechst stained for counting.
Statistics
Data are presented as means + SD for at least four samples or four repeated individual experiments per group. Statistical analysis used GraphPad Figure S2 ). Cells harvested from the blood MNC culture were of various sizes and shapes. The big and cobblestone-shaped cells were sparse. Apart from only a few blood-derived cells, almost all of the BM-derived cells were double-positive for Dil-acLDL uptake and FITC-lectin binding ( Figure 1A) . Over 97% of the BM-derived cells were CD144 + , CD14
2
, and CD45
, while only 9% of the blood-derived cells were CD144 + ( Figure 1B) . The BM-derived cells after 28 days of culture, compared with those after 0 and 7 days of culture, produced the highest amount of NO during 24 h stimulation by bradykinin ( Figure 1C) . In addition, all of the /kg Dil-acLDL-incorporated OECs did not reduce neointima formation (day 28). Arrows point to the internal elastic lamina, the boundary between intima and media.
Late Figure 1D ). These data collectively suggest that directionally culturing autologous BM MNCs results in numerous and comparatively pure OECs harvest. Accordingly, in the following experiments, the BM-derived OECs were used.
OECs migrate and form tubes in vitro
The modified Boyden chamber assay showed that OECs had a timedependent migratory ability (Figure 2A and B) . In the absence of Matrigel Matrix, the newly plated OECs attached to the dish bottom and contacted each other within 24 h of culture ( Figure 2C ). In the presence of Matrigel Matrix, however, most of the OECs integrated to form tubule networks, and most of the tubes were generally composed of a single layer of OECs ( Figure 2D ).
Transfusion of autologous OECs reduces rabbit ear central arterial neointima formation after injury
As shown in Figure 3 and Table 1 , in the PBS (model) group, the intima area of the ear central artery was significantly increased (P , 0.01) on day 14 after injury, while the media and lumen areas remained unchanged (P . 0.05); on day 28, the lumen area was significantly decreased (P , 0.01), while the intima area was further increased, and the media area was still unchanged. Transfusion of 2 × 10 6 /kg OECs reduced the increase of intima area on days 14 (P , 0.01) and 28 (P , 0.05) , and the decrease of lumen area on day 28 (P , 0.05). Transfusion of 1 × 10 7 /kg OECs significantly reduced the increase of intima areas and the decrease of lumen areas (P , 0.01) on days 14 and 28. The lumen areas were close to normal. Transfusion of Dil-acLDL-incorporated OECs did not alter the increase in intima area and decrease in lumen area (day 28, P . 0.05). In addition, red fluorescence was seen in the injured arteries of rabbits that received Dil-acLDL-incorporated OECs. The fluorescence was intense on day 2 -3 and disappeared 7 days later.
Transfusion of autologous OECs ameliorates inflammatory and angiogenic responses to the arterial injury
Compared with PBS, transfusion of OECs (1 × 10 7 /kg) lowered the rabbit serum C-reactive protein levels on days 2 and 7, serum SDF-1 levels on days 2 and 7, leucocyte AIF-1 expression on days 2 and 7, and the injured ear central artery AIF-1, SDF-1, and TNF-a expressions on day 7 (P , 0.05 or 0.01). Compared with PBS, the transfusion of OECs raised the rabbit serum levels of VEGF and interleukin-8 on day 7, and the injured artery eNOS expression on day 7 (P , 0.05 or 0.01, Figure 4 ).
OECs adhere to the injured artery and are present in the rescued artery
After 1 h of perfusion of the rabbit ear, intense red fluorescence was seen in the injured part, but in not other parts of the ear central artery (n ¼ 4). The fluorescence was seen in vasculature-intact ears (n ¼ 5) and in the central artery of injured ears treated with collagen type I antibody (n ¼ 4). The phenomena were verified by fluorescent and/or immunofluorescent analysis of arterial sections ( Figure 5A) .
We have mentioned above that red fluorescence was seen in situ in the injured artery within 7 days post-transfusion of Dil-acLDL-incorporated OECs. In a separate experiment, intense fluorescence was seen on the surface of the injured arterial intima on day 3 (Figure 5Ba ). After transfusion of BrdU-incorporated OECs (1 × 10 7 /kg), BrdU-positive cells were seen in the injured arterial intima (day 3, n ¼ 4; Figure 5Bc) , and in the rescued arterial endothelium (day 28, n ¼ 4; Figure 5Be ).
OECs and OEC-conditioned medium inhibit proliferation and migration of VSMCs, and permit rearrangement of VSMCs
Microscopic observation showed that culture of VSMCs alone resulted in an increase in their number and a cluster-like arrangement, implying proliferation (n ¼ 4; Figure 6A ). Proliferation slowed down when OECs (the number of which was 10% of the VSMCs, n ¼ 4; Figure 6B) The right ear central artery of the rabbit was used in the same period as the intact artery. Data are presented as means + SD, n ¼ 5 in each group. *P , 0.05, **P , 0.01 vs. the same period in the PBS group. Abbreviations: Dil-acLDL-OECs, 1,1
′ -tetramethylindocarbocyanine-labelled acetylated low-density lipoprotein-incorporrated OECs (1 × 10 OEC-conditioned medium (10%, n ¼ 4; Figure 6C ) was present in the culture system. The MTT assay confirmed the inhibitory effects of OECs and OEC-conditioned medium on proliferation of the VSMCs ( Figure 6E ). Microscopic observation also revealed that OECs interacted with VSMCs and formed tube-like structures. The OECs were in the inner layer of the tube, and VSMCs in the outer. There were no VSMCs in the lumen ( Figure 6B ). In the presence of the OECconditioned medium, VSMCs alone could form tube-like structures ( Figure 6C ). Co-culture of OECs and VSMCs (the number of which was 10% of OECs, n ¼ 4) resulted in formation of a tubule network mainly by OECs, and production of connections between the two cell types ( Figure 6D) . A modified Boyden chamber assay showed that OECs inhibited migration of VSMCs in a number-dependent manner, and the OEC-conditioned medium inhibited migration of VSMCs in a concentration-dependent manner ( Figure 6F ).
Discussion
It has been reported that transfusion of human OECs reduced arterial neointima formation by a paracrine pathway in immunodeficient mice, 26, 27 while local seeding of allogenic OECs failed to prevent arterial intima hyperplasia in immunointact rats. 5 The results of the present study suggest that transfusion of OECs ameliorates early local and systemic inflammatory and angiogenic responses to arterial injury, and reduces neointima formation. The OECs are able to adhere to the sites of injury and differentiate into ECs. The OECs Late-outgrowth endothelial cells in arterial re-endothelialization also, by a paracrine pathway, inhibit proliferation and migration of VSMCs, and regulate the arrangement of VSMCs. For technical reasons, it has so far proved difficult to purposefully mobilize sufficient OECs to circulating blood from other organs. Granulocyte colony-stimulating factor plus erythropoietin injection not only enhances the blood level of OECs, but also elevates the blood level of eEPCs and thus aggravates arterial neointima formation. 18 Therefore, to investigate whether and how endogenous OECs participate in re-endothelialization and reduce neointima formation, our tactic is to transfuse in vitro amplified autologous OECs soon after arterial injury. We selected rabbits for this study because enough peripheral blood and BM can be drawn from a rabbit to amplify OECs numbers without killing the rabbit.
After 4-7 days of directionally culturing MNCs from blood, BM or spleen, eEPCs appear; they do not proliferate, and will disappear within 4 weeks. 8 OECs are scarce, and start to proliferate after 2-3 weeks; 22 their progeny can be subcultured for more than 20 passages. 8, 19 Therefore, we cultured blood-and BM-derived MNCs for 4 weeks to increase the number of OECs. eEPCs are spindle-shaped cells. 8 OECs have a cobblestone morphology. 22 Both cell types take up LDL, bind to Ulex europaeus agglutinin, and express CD31, CD34, CD144, VEGF receptor 2, and von Willebrand factor. 23 The eEPCs express CD14 and CD45. 8, 23 The OECs do not express CD14 and CD45, 8 but express eNOS and caveolin-1. 8, 24 OECs, but not eEPCs, are able to form vascular networks in vitro. 8 Our data
show that culturing BM MNCs resulted in a harvest of numerous and pure OECs; OECs represent a small proportion of the cells harvested from blood MNC culture. This phenomenon has not been found in the literature. Rabbit ear central artery intima hyperplasia is a model we developed and this is the first report to describe it. The ear central artery was selected for the following reasons: (1) the rabbit ear central artery, like the coronary artery, is a medium-sized artery; (2) rabbit ear is thin, and the ear central artery is superficial, which means that adherence of fluorescently labelled OECs to the artery can be visualized in situ and real time using an inverted fluorescence microscope; and (3) the rabbit ear central artery is easily accessible. On day 14 post-injury, the intima area increased on average to 25.3 times its original size, and the lumen area decreased by 23.6%; on day 28, the intima area increased to 36.5 times, and the lumen area decreased by 64.3%.
Although heparinized, some rabbits suffered from severe thrombosis, which could be recognized by touching the ear skin; the lower arterial pulses stopped. Thrombus in most of the rabbits was broken down within 3 h. The rabbits with thrombus remaining for up to 4 h had to be killed. Therefore, OECs were injected 4 h after injury. The lumen areas on days 14 and 28 after transfusion of 1 × 10 7 /kg of OECs were close to normal, implying that OECs not only inhibit the encroachment of VSMCs, but also accelerate re-endothelialization. This implication was supported by the following Figure 6 Interactions between autologous OECs and VSMCs in vitro. data. Dil-acLDL-incorporated OECs failed to prevent neointima formation, suggesting that LDL uptake is a bad thing for OECs.
The correlation between C-reactive protein and restenosis is in dispute. Autologous transfusion of OECs reduced the enhancement of blood C-reactive protein levels early after arterial injury. Tumour necrosis factor-a is a cytokine recognised for induction of inflammation and neointima formation, and AIF-1 is a cytosolic calciumbinding protein, which can be induced by injury and inflammatory cytokines and play roles in development of vascular intima hyperplasia. 32 Our data showed that OECs reduced the expression of TNF-a and AIF-1. The decrease of SDF-1 expression reflects the finding that chemotaxis for inflammatory cells and other cell types, including OECs, was subdued by the transfused OECs. Interleukin-8, a chemoattractant and an angiogenic factor, has beneficial effects on EC proliferation and survival. 33 The enhancement of blood interleukin-8
and VEGF levels by the OECs is good for endothelial repair, which is in line with the enhancement of eNOS expression in the injured artery.
Endothelial denudation leads to collagen exposure to blood. Rabbit ear perfusion reveals that circulating OECs can adhere to the injured artery soon after injury, and collagen type I plays a role in the process. Mesenchymal stem cells, which can differentiate into VSMCs and contribute to neointima formation, are unable to adhere to injured vasculature within the first 2 days. 26 Accordingly, the OECs should be injected as soon as possible.
Intense fluorescence was seen within 7 days after transfusion of Dil-acLDL-incorporated OECs, and BrdU-positive cells appeared on day 3 after transfusion of BrdU-incorporated OECs into the injured artery, supporting the adhesion of OECs. The BrdU-positive cells existed in the endothelium of the rescued artery, supporting the direct differentiation of OECs into ECs.
Heterogenous OECs reduced neointima formation by releasing pigment epithelium-derived factor to inhibit migration and proliferation of VSMCs. 27 Our data show that autologous OECs are able, through a paracrine pathway, to inhibit proliferation and migration of VSMCs, although what OECs release remains unknown. Our data also suggest that OECs regulate the arrangement of VSMCs, through a paracrine pathway,. In summary, the present study demonstrates that the following: (1) circulating OECs can adhere to sites of endothelial injury to participate in re-endothelialization directly and inhibit migration and proliferation of VSMCs by a paracrine pathway; and (2) transfusion of large numbers of autologous OECs soon after vascular injury may prevent neointima formation. The study opens a new way to inhibit the restenosis process after revascularization procedures such as percutaneous balloon angioplasty, stent implantation, or atherectomy. During therapy with OECs, blood lipid levels should be controlled in the normal range.
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